Clinical trial
Sequencing Of Endocrine Therapy In Post-Menopausal Women With Early Breast Cancer (FAST) a Non-interventional Trial With Aromasin®
NCT01050634 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sequencing Of Endocrine Therapy In Post-Menopausal Women With Early Breast Cancer (FAST) a Non-interventional Trial With Aromasin®
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2005
- Completion date
- April 30, 2009
- Enrollment
- 980 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
post menopausal women with early breast cancer